New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 6, 2013
11:50 EDTAMAGAMAG Pharmaceuticals sees FY13 year-end cash/investment $206M-$211M
A 2013 year-end cash and investments balance of between $206 million and $211 million, not including the impact of business development transactions.
News For AMAG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for AMAG

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use